International Stem Cell (ISCO) Gross Profit (2010 - 2026)
International Stem Cell (ISCO) posted Gross Profit of $1.46 million for Q2 2026, down 4.1% from $1.52 million a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Gross Profit (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at International Stem Cell was $5.39 million, up 1.3% year-over-year; for FY2025, it came in at $5.07 million, down 4.8% from FY2024.
- Annual Gross Profit shows a five-year compound annual growth rate of 3.1% (FY2020 to FY2025).
- In prior years, International Stem Cell's Gross Profit was $5.32 million in FY2024 (+15.5%), $4.61 million in FY2023 (-6.2%), $4.91 million in FY2022 (+15.8%) and $4.24 million in FY2021 (-2.4%).
- Quarterly Gross Profit has run from a low of $1.01 million in Q3 2022 to a high of $1.52 million in Q2 2025 over five years.
- On a year-over-year basis, Gross Profit increased in four of the last seven quarters, with growth averaging 3.2%.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q4 2024, with growth of 41.9%; the weakest was Q4 2025, with a decline of 25.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | International Stem Cell | 1.36 Mn | -2.61 Mn | 1.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.46 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.03 Mn |
| Sep 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.11 Mn |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 1.06 Mn |
API Access
International Stem Cell Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();